Selected article for: "entry process and host cell"
Author: Kang, Yuan-Lin; Chou, Yi-ying; Rothlauf, Paul W.; Liu, Zhuoming; Soh, Timothy K.; Cureton, David; Case, James Brett; Chen, Rita E.; Diamond, Michael S.; Whelan, Sean P. J.; Kirchhausen, Tom
Title: Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
  • Cord-id: kbjyd5g3
  • Document date: 2020_8_25
    • ID: kbjyd5g3
    Snippet: Virus entry is a multistep process. It initiates when the virus attaches to the host cell and ends when the viral contents reach the cytosol. Genetically unrelated viruses can subvert analogous subcellular mechanisms and use similar trafficking pathways for successful entry. Antiviral strategies targeting early steps of infection are therefore appealing, particularly when the probability for successful interference through a common step is highest. We describe here potent inhibitory effects on c
    Document: Virus entry is a multistep process. It initiates when the virus attaches to the host cell and ends when the viral contents reach the cytosol. Genetically unrelated viruses can subvert analogous subcellular mechanisms and use similar trafficking pathways for successful entry. Antiviral strategies targeting early steps of infection are therefore appealing, particularly when the probability for successful interference through a common step is highest. We describe here potent inhibitory effects on content release and infection by chimeric vesicular stomatitis virus (VSV) containing the envelope proteins of Zaire ebolavirus (VSV-ZEBOV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (VSV-SARS-CoV-2) elicited by Apilimod and Vacuolin-1, small-molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve. We also describe potent inhibition of SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020 by Apilimod. These results define tools for studying the intracellular trafficking of pathogens elicited by inhibition of PIKfyve kinase and suggest the potential for targeting this kinase in developing small-molecule antivirals against SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • activation proteolytic processing and acute sars cov respiratory syndrome coronavirus: 1, 2
    • active remain and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • active remain and lysosome endosome: 1
    • acute sars cov respiratory syndrome coronavirus and live cell imaging: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and lymphocytic choriomeningitis virus: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and lysosome endosome: 1, 2, 3, 4, 5